🧠 The neurological effects of #COVID19 are one of the most troubling and persistent legacies of the pandemic. Even long after the acute phase, many people continue to experience cognitive symptoms—such as memory loss, attention deficits, and even signs of structural brain atrophy—that impact daily functioning and long-term well-being. A recent meta-analysis involving more than 4 million patients clearly demonstrates the high prevalence of these long-term cognitive symptoms, underscoring the urgent need to improve long-term follow-up and early intervention strategies. Complementing this, earlier MRI-based studies have shown measurable brain volume loss in key regions such as the hippocampus, cerebellum, and orbitofrontal cortex—providing objective evidence of structural changes behind persistent symptoms. On #WorldBrainDay, we highlight the importance of protecting brain health and the role that advanced imaging tools like QP-Brain can play in detecting early signs of cerebral atrophy—especially when conventional MRI appears normal. 📑 Reference studies: 🔹 https://lnkd.in/dPgTPW-n 🔹 https://lnkd.in/dMP6AbvT #BrainHealth #Neurology #Prevention #MedicalImaging
Following our recent webinar 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐂𝐚𝐬𝐞 𝐒𝐞𝐬𝐬𝐢𝐨𝐧: 𝐀𝐈 𝐢𝐧 𝐩𝐫𝐨𝐬𝐭𝐚𝐭𝐞 𝐜𝐚𝐧𝐜𝐞𝐫 - 𝐕𝐨𝐥.2, endorsed by SERAM - Sociedad Española de Radiología Médica, what are top clinicians saying about QP-Prostate? If you were unable to attend live, you can now watch the full session. Find out how AI is being used in real clinical workflows and why these expert-led discussions are essential to advance practice, support confident diagnosis, and ultimately improve outcomes for prostate cancer patients. https://bit.ly/44Lo2W0 #Radiology #HealthcareInnovation #AI hashtag #MedicalImaging #QPProstate #webinar
Despite the increasing adoption of prostate MRI in clinical practice, a significant and underestimated challenge remains: 1 in 3 prostate MRI scans is of insufficient diagnostic quality. This variability directly impacts clinical outcomes, as suboptimal images challenge the detection and exclusion of clinically significant prostate cancers. To address this problem, we have introduced AI-QUAL™, an innovative feature in our QP-Prostate platform that automates image quality assessment based on PI-QUAL v2 guidelines, helping to ensure that all scans meet the standards patients deserve. Read everything about it: https://bit.ly/3Ieh04g #MedicalImaging #AIinHealthcare #ProstateCancer #DigitalHealth #PIQUAL #PIRADS #AIQUAL
📊 What did Q2 bring for Quibim? We’re proud to share that the number of patients analyzed with Quibim's technology grew by an outstanding 241% compared to the same dates last year. That means many more patients are benefiting from better diagnostics—proof that we’re moving in the right direction. In our latest quarterly newsletter, we also explore: 🔹 Exciting innovations that are shaping medical imaging and healthcare tech. 🔹 Partnerships that amplify our impact on patients globally. Discover it all here 👉 https://lnkd.in/dj9ybMpf
We’re proud to share that QP-Prostate has been selected for a major NHS England-backed rollout to support the early detection of prostate cancer across 7 hospitals in England. Over the next two years, QP-Prostate will assess over 3,000 patients, evaluating its impact on diagnostic accuracy, cost-effectiveness, and health equity. #ProstateCancer remains a major health challenge in the UK. Despite advances in care, only half of cases are diagnosed early — when treatment has the highest impact. The NHS Long Term Plan aims to raise this to 75% by 2028. This rollout has been made possible through the SBRI Healthcare (Small Business Research Initiative), which enables the NHS to access innovative companies with mature technologies and demonstrate real-world clinical benefits to accelerate adoption in practice. https://bit.ly/4nIN94w #AIinHealthcare #NHS #Radiology #EarlyDetection #DigitalHealth
Despite a low PSA (2), a strong family history in which both father and brother had #ProstateCancer raised clinical concern. With the support of QP-Prostate, the lesion was clearly flagged as suspicious. A biopsy confirmed the diagnosis and allowed timely treatment. The patient recovered without complications and returned home with an encouraging prognosis: 100% 5-year survival for localized prostate cancer. A clear example of how #AI can contribute to accuracy and confidence in clinical decision making. ▶️ Watch the full case here: https://lnkd.in/dhy2RB3e Kai Vilanova MD, PhD #AIinHealth #HealthInnovation #QPProstate
As Dr Carlos Camps Herrero states, “innovation in oncology is no longer a question of if—but when.” In our conversation with Prof. Camps, we explore the barriers that still stand in the way of implementing transformative technologies such as AI, radiomics and molecular diagnostics. Dive into the full article to discover how we can bridge the gap between potential and real-world impact 👉 https://bit.ly/4nDHsor #Oncology #PrecisionMedicine #PublicHealth #AIinHealth #MedicalEducation #HealthInnovation
Advanced prostate cancer survival has tripled in the last 15 years, according to Sociedad Española de Oncología Médica (SEOM), thanks to: ➡️ Next-gen hormonal therapies ➡️ Novel chemotherapies and radioisotopes ➡️ PARP inhibitors for patients with BRCA1/2 mutations These advances are extending survival and improving quality of life through biomarker-guided, personalized strategies. At Quibim, we support this progress with QP-Prostate®, our AI-powered solution for earlier, more precise detection of aggressive prostate cancer. By standardizing interpretation and identifying lesions automatically, QP-Prostate® enables faster, more confident decisions in precision oncology. Innovation in diagnostics is saving lives. Let’s keep pushing forward. #ProstateCancer #PrecisionMedicine #AIinRadiology #MedicalImaging #QPProstate #OncologyInnovation #SEOM2025 #ImagingBiomarkers
In June, we participated in important discussions and listened closely to the needs of the clinical community. Through our presence at major industry events and the development of high-impact new features, we continued to work toward solutions that improve diagnostic accuracy, facilitate confident decision-making, and ultimately lead to better outcomes for patients. Stay up to date through our monthly newsletter 👇 #AIinHealthcare #Oncology #MedicalImaging #Innovation #PrecisionMedicine
We would like to thank everyone who joined our webinar endorsed by SERAM - Sociedad Española de Radiología Médica, 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐂𝐚𝐬𝐞 𝐒𝐞𝐬𝐬𝐢𝐨𝐧: 𝐀𝐈 𝐢𝐧 𝐩𝐫𝐨𝐬𝐭𝐚𝐭𝐞 𝐜𝐚𝐧𝐜𝐞𝐫 - 𝐕𝐨𝐥.2, where Dr. Fernando Losada from Argentina and Dr. Milagros Otero-García from Spain, shared real clinical cases and demonstrated how artificial intelligence is transforming daily medical practice. It was a valuable opportunity to explore real-life applications and discuss their impact on clinical decision making. If you were unable to attend live, you can watch the full session here: https://bit.ly/4493tDJ #Radiology #HealthcareInnovation #AI #MedicalImagin #QPProstate #webinar
